Cargando…

Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study

Detalles Bibliográficos
Autores principales: Machida, Hiroko, Matsuo, Koji, Enomoto, Takayuki, Mikami, Mikio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779622/
https://www.ncbi.nlm.nih.gov/pubmed/31576698
http://dx.doi.org/10.3802/jgo.2019.30.e113
_version_ 1783456941595426816
author Machida, Hiroko
Matsuo, Koji
Enomoto, Takayuki
Mikami, Mikio
author_facet Machida, Hiroko
Matsuo, Koji
Enomoto, Takayuki
Mikami, Mikio
author_sort Machida, Hiroko
collection PubMed
description
format Online
Article
Text
id pubmed-6779622
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
record_format MEDLINE/PubMed
spelling pubmed-67796222019-11-01 Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study Machida, Hiroko Matsuo, Koji Enomoto, Takayuki Mikami, Mikio J Gynecol Oncol Correspondence Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019-09-03 /pmc/articles/PMC6779622/ /pubmed/31576698 http://dx.doi.org/10.3802/jgo.2019.30.e113 Text en Copyright © 2019. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Machida, Hiroko
Matsuo, Koji
Enomoto, Takayuki
Mikami, Mikio
Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
title Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
title_full Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
title_fullStr Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
title_full_unstemmed Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
title_short Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
title_sort neoadjuvant chemotherapy for epithelial ovarian cancer in japan: a jsgo-jsog joint study
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779622/
https://www.ncbi.nlm.nih.gov/pubmed/31576698
http://dx.doi.org/10.3802/jgo.2019.30.e113
work_keys_str_mv AT machidahiroko neoadjuvantchemotherapyforepithelialovariancancerinjapanajsgojsogjointstudy
AT matsuokoji neoadjuvantchemotherapyforepithelialovariancancerinjapanajsgojsogjointstudy
AT enomototakayuki neoadjuvantchemotherapyforepithelialovariancancerinjapanajsgojsogjointstudy
AT mikamimikio neoadjuvantchemotherapyforepithelialovariancancerinjapanajsgojsogjointstudy